Results 201 to 210 of about 27,792 (251)

Pre-emptive <i>CYP2C19</i> genotyping and voriconazole exposure in pediatric hematology patients at risk of aspergillosis: an exploratory randomized pilot study with a cost-consequence analysis. [PDF]

Front Pharmacol
Monserrat-Villatoro J, Bueno D, Estébanez M, Mozo Y, Rosas-Alonso R, Antón C, Otero MJ, Guerra-García P, Díaz-Villamarín X, Arias P, Pérez-Martínez A, Abad-Santos F, Carcas AJ, García-García I, Borobia AM.   +14 more
europepmc   +1 more source

Impact of CYP2C19 and CYP3A4 Inhibitor Use on Clopidogrel Clinical Effectiveness in CYP2C19 Genotyped Patients Undergoing Percutaneous Coronary Intervention. [PDF]

Clin Pharmacol Ther
Shao D, Malavé JG, Rossi JS, Franchi F, Keeley EC, Angiolillo DJ, Stouffer GA, Cavallari LH, Lee CR.   +8 more
europepmc   +1 more source

Analysis of molecular targets and mechanisms of Bisphenol F (BPF)-induced non-alcoholic fatty liver disease (NAFLD) based on network toxicology and molecular dynamics. [PDF]

PLoS One
Wang R, Liao Q, Liu X, Sun L, Xia Y.
europepmc   +1 more source

A primary care pharmacogenetic precision medicine pilot based on specific Māori tribal ethical frameworks and principles. [PDF]

J Community Genet
Robertson SP, Halliday BJ, Tibble R, Koia C, Haereroa T, Goodin E, Curran B, Rye CE, Wihongi H, Aika BT, de Ligt J, Macartney-Coxson D, Jones N, Huh J, Perkins EO, Pestle M, Zhao K, Kennedy MA, Gladding PA, Markie DM, Print CG, Wilcox PL, Puketapu-Watson H.   +22 more
europepmc   +1 more source

Successful treatment of severe influenza-associated pulmonary aspergillosis with invasive tracheobronchitis and bronchial asthma using combination antifungals and omalizumab: A case report. [PDF]

IDCases
Du W, Lv H, Ni Y, Ding Y.
europepmc   +1 more source

Machine Learning With Genetic and Clinical Data to Predict Ischemic Outcomes After PCI. [PDF]

Clin Transl Sci
Grant CW, Ingraham BS, Lennon RJ, Raina A, Tian S, Kowlgi G, Cavallari LH, Lee CR, Beitelshees A, Angiolillo DJ, Franchi F, Duarte JD, Rossi JS, Stouffer GA, Klee E, Gulati R, Rihal C, Farkouh M, Athreya AP, Pereira NL.   +19 more
europepmc   +1 more source

Pharmacogenetic phenoconversion modeling of drug–drug–gene interactions on CYP2C19 activity: effects of comedication by genotype on escitalopram concentrations

Stingl J, Molden E, Hole K, Wollmann BM, Viviani R.   +4 more
europepmc   +1 more source

Effectiveness of CYP2C19 Genotype-Guided Antiplatelet Therapy Following Neurovascular Endovascular Procedures: A Prospective Non-Randomized Controlled Study. [PDF]

Ther Clin Risk Manag
Xu S, Wang X, Cui G, Li M, Chen G, Hu J, Zhang Q.   +6 more
europepmc   +1 more source

Association of <i>ABCB1</i> and <i>CYP2C19</i> polymorphisms with major adverse cardiovascular complications in patients taking clopidogrel. [PDF]

Front Cardiovasc Med
Khasawneh LQ, Alqasrawi MN, Al-Mahayri ZN, Dabaghie L, Altoum SM, Jamil G, Aburuz S, Hamza D, George L, Al-Bakshy F, Al-Anee K, AlAhamad K, Al-Maskari F, Ouda H, AlKaabi J, Patrinos GP, Ali BR.   +16 more
europepmc   +1 more source